Citation: Bt. Volpe et al., BRAIN-DERIVED NEUROTROPHIC FACTOR PREVENTS THE LOSS OF NIGRAL NEURONSINDUCED BY EXCITOTOXIC STRIATAL-PALLIDAL LESIONS, Neuroscience, 83(3), 1998, pp. 741-748
Citation: Dm. Yurek et al., OPTIMAL EFFECTIVENESS OF BDNF FOR FETAL NIGRAL TRANSPLANTS COINCIDES WITH THE ONTOGENIC APPEARANCE OF BDNF IN THE STRIATUM, The Journal of neuroscience, 18(15), 1998, pp. 6040-6047
Authors:
GALPERN WR
FRIM DM
TATTER SB
ALTAR CA
BEAL MF
ISACSON O
Citation: Wr. Galpern et al., CELL-MEDIATED DELIVERY OF BRAIN-DERIVED NEUROTROPHIC FACTOR ENHANCES DOPAMINE LEVELS IN AN MPP-NIGRA DEGENERATION( RAT MODEL OF SUBSTANTIA), Cell transplantation, 5(2), 1996, pp. 225-232
Citation: Mt. Martiniverson et Ca. Altar, SPONTANEOUS BEHAVIORS OF RATS ARE DIFFERENTIALLY AFFECTED BY SUBSTANTIA-NIGRA INFUSIONS OF BRAIN-DERIVED NEUROTROPHIC FACTOR AND NEUROTROPHIN-3, European journal of neuroscience, 8(8), 1996, pp. 1696-1706
Authors:
ARENAS E
AKERUD P
WONG V
BOYLAN C
PERSSON H
LINDSAY RM
ALTAR CA
Citation: E. Arenas et al., EFFECTS OF BDNF AND NT-4 5 ON STRIATONIGRAL NEUROPEPTIDES OR NIGRAL GABA NEURONS IN-VIVO/, European journal of neuroscience, 8(8), 1996, pp. 1707-1717
Authors:
ALDERSON RF
WIEGAND SJ
ANDERSON KD
CAI N
CHO JY
LINDSAY RM
ALTAR CA
Citation: Rf. Alderson et al., NEUROTROPHIN-4 5 MAINTAINS THE CHOLINERGIC PHENOTYPE OF AXOTOMIZED SEPTAL NEURONS/, European journal of neuroscience, 8(2), 1996, pp. 282-290
Authors:
CELADA P
SIUCIAK JA
TRAN TM
ALTAR CA
TEPPER JM
Citation: P. Celada et al., LOCAL INFUSION OF BRAIN-DERIVED NEUROTROPHIC FACTOR MODIFIES THE FIRING PATTERN OF DORSAL RAPHE SEROTONERGIC NEURONS, Brain research, 712(2), 1996, pp. 293-298
Authors:
SIUCIAK JA
BOYLAN C
FRITSCHE M
ALTAR CA
LINDSAY RM
Citation: Ja. Siuciak et al., BDNF INCREASES MONOAMINERGIC ACTIVITY IN RAT-BRAIN FOLLOWING INTRACEREBROVENTRICULAR OR INTRAPARENCHYMAL ADMINISTRATION, Brain research, 710(1-2), 1996, pp. 11-20
Authors:
JONES BE
BOYLAN CB
FRITSCHE M
JUHASZ M
JACKSON C
WIEGAND SJ
HYMAN C
LINDSAY RM
ALTAR CA
Citation: Be. Jones et al., A CONTINUOUS STRIATAL INFUSION OF 6-HYDROXYDOPAMINE PRODUCES A TERMINAL AXOTOMY AND DELAYED BEHAVIORAL-EFFECTS, Brain research, 709(2), 1996, pp. 275-284
Citation: Sf. Radka et al., PRESENCE OF BRAIN-DERIVED NEUROTROPHIC FACTOR IN BRAIN AND HUMAN AND RAT BUT NOT MOUSE SERUM DETECTED BY A SENSITIVE AND SPECIFIC IMMUNOASSAY, Brain research, 709(1), 1996, pp. 122-130
Authors:
STUDER L
SPENGER C
SEILER RW
ALTAR CA
LINDSAY RM
HYMAN C
Citation: L. Studer et al., COMPARISON OF THE EFFECTS OF THE NEUROTROPHINS ON THE MORPHOLOGICAL STRUCTURE OF DOPAMINERGIC-NEURONS IN CULTURES OF RAT SUBSTANTIA-NIGRA, European journal of neuroscience, 7(2), 1995, pp. 223-233
Citation: La. Mamounas et al., BRAIN-DERIVED NEUROTROPHIC FACTOR PROMOTES THE SURVIVAL AND SPROUTINGOF SEROTONERGIC AXONS IN RAT-BRAIN, The Journal of neuroscience, 15(12), 1995, pp. 7929-7939
Authors:
ANDERSON KD
ALDERSON RF
ALTAR CA
DISTEFANO PS
CORCORAN TL
LINDSAY RM
WIEGAND SJ
Citation: Kd. Anderson et al., DIFFERENTIAL DISTRIBUTION OF EXOGENOUS BDNF, NGF, AND NT-3 IN THE BRAIN CORRESPONDS TO THE RELATIVE ABUNDANCE AND DISTRIBUTION OF HIGH-AFFINITY AND LOW-AFFINITY NEUROTROPHIN RECEPTORS, Journal of comparative neurology, 357(2), 1995, pp. 296-317
Authors:
ALTAR CA
SIUCIAK JA
WRIGHT P
IP NY
LINDSAY RM
WIEGAND SJ
Citation: Ca. Altar et al., IN-SITU HYBRIDIZATION OF TRKB AND TRKC RECEPTOR MESSENGER-RNA IN RAT FOREBRAIN AND ASSOCIATION WITH HIGH-AFFINITY BINDING OF [I-125] BDNF, [I-125] NT-4 5 AND [I-125] NT-3/, European journal of neuroscience, 6(9), 1994, pp. 1389-1405
Citation: Mt. Martiniverson et al., BRAIN-DERIVED NEUROTROPHIC FACTOR AND NEUROTROPHIN-3 ACTIVATE STRIATAL DOPAMINE AND SEROTONIN METABOLISM AND RELATED BEHAVIORS - INTERACTIONS WITH AMPHETAMINE, The Journal of neuroscience, 14(3), 1994, pp. 1262-1270
Citation: Ry. Shen et al., BRAIN-DERIVED NEUROTROPHIC FACTOR INCREASES THE ELECTRICAL-ACTIVITY OF PARS COMPACTA DOPAMINE NEURONS IN-VIVO, Proceedings of the National Academy of Sciences of the United Statesof America, 91(19), 1994, pp. 8920-8924
Authors:
ALTAR CA
BOYLAN CB
FRITSCHE M
JONES BE
JACKSON C
WIEGAND SJ
LINDSAY RM
HYMAN C
Citation: Ca. Altar et al., EFFICACY OF BRAIN-DERIVED NEUROTROPHIC FACTOR AND NEUROTROPHIN-3 ON NEUROCHEMICAL AND BEHAVIORAL DEFICITS ASSOCIATED WITH PARTIAL NIGROSTRIATAL DOPAMINE LESIONS, Journal of neurochemistry, 63(3), 1994, pp. 1021-1032
Authors:
ALTAR CA
BOYLAN CB
FRITSCHE M
JACKSON C
HYMAN C
LINDSAY RM
Citation: Ca. Altar et al., THE NEUROTROPHINS NT-4 5 AND BDNF AUGMENT SEROTONIN, DOPAMINE, AND GABAERGIC SYSTEMS DURING BEHAVIORALLY EFFECTIVE INFUSIONS TO THE SUBSTANTIA-NIGRA/, Experimental neurology, 130(1), 1994, pp. 31-40
Authors:
SHULTS CW
MATTHEWS RT
ALTAR CA
HILL LR
LANGLAIS PJ
Citation: Cw. Shults et al., SINGLE INTRAMESENCEPHALIC INJECTION OF BRAIN-DERIVED NEUROTROPHIC FACTOR INDUCES PERSISTENT ROTATIONAL ASYMMETRY IN RATS, Experimental neurology, 125(2), 1994, pp. 183-194
Authors:
SIUCIAK JA
ALTAR CA
WIEGAND SJ
LINDSAY RM
Citation: Ja. Siuciak et al., ANTINOCICEPTIVE EFFECT OF BRAIN-DERIVED NEUROTROPHIC FACTOR AND NEUROTROPHIN-3, Brain research, 633(1-2), 1994, pp. 326-330
Authors:
MORSE JK
WIEGAND SJ
ANDERSON K
YOU YM
CAI N
CARNAHAN J
MILLER J
DISTEFANO PS
ALTAR CA
LINDSAY RM
ALDERSON RF
Citation: Jk. Morse et al., BRAIN-DERIVED NEUROTROPHIC FACTOR (BDNF) PREVENTS THE DEGENERATION OFMEDIAL SEPTAL CHOLINERGIC NEURONS FOLLOWING FIMBRIA TRANSECTION, The Journal of neuroscience, 13(10), 1993, pp. 4146-4156